Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001641172-25-010405
Filing Date
2025-05-15
Accepted
2025-05-14 19:19:04
Documents
73
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q form10-q.htm   iXBRL 10-Q 1014757
2 EX-31.1 ex31-1.htm EX-31.1 18438
3 EX-31.2 ex31-2.htm EX-31.2 18462
4 EX-32.1 ex32-1.htm EX-32.1 8517
5 EX-32.2 ex32-2.htm EX-32.2 8468
  Complete submission text file 0001641172-25-010405.txt   6486053

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE cdt-20250331.xsd EX-101.SCH 53903
7 XBRL CALCULATION FILE cdt-20250331_cal.xml EX-101.CAL 62165
8 XBRL DEFINITION FILE cdt-20250331_def.xml EX-101.DEF 283253
9 XBRL LABEL FILE cdt-20250331_lab.xml EX-101.LAB 462151
10 XBRL PRESENTATION FILE cdt-20250331_pre.xml EX-101.PRE 377619
75 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 895237
Mailing Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103 (646) 491 9132
CONDUIT PHARMACEUTICALS INC. (Filer) CIK: 0001896212 (see all company filings)

EIN.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41245 | Film No.: 25947783
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)